Non-Small Cell Lung Cancer (ROS Marker Positive)
Also known as: Non-small Cell Lung Cancer Harboring ROS1 Rearrangement / ROS1 Rearrangement Non-small Cell Lung Cancer / ROS1-positive Non-Small Cell Lung Cancer (NSCLC) / Non-Small Cell Lung Cancer ROS Marker Positive
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08865 | Crizotinib | 1 | Completed | 1 |
| DB01167 | Itraconazole | 1 | Completed | 1 |
| DB01045 | Rifampicin | 1 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB09063 | Ceritinib | 2 | Unknown Status | 1 |
| DB09078 | Lenvatinib | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Recruiting | 1 |